medigraphic.com
SPANISH

Medicina Interna de México

Colegio de Medicina Interna de México.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2024, Number 04

<< Back Next >>

Med Int Mex 2024; 40 (04)

Goya's The Fates: Meeting Klotho

Parra GR, Corona RE
Full text How to cite this article

Language: Spanish
References: 9
Page: 271-275
PDF size: 251.30 Kb.


Key words:

No keywords

Text Extraction

No abstract.


REFERENCES

  1. Las Parcas (átropos). Colección Museo Nacional del Prado. https://www.museodelprado.es/coleccion/obra-de-arte/las-parcas-atropos/8c8672a8-953e-4c00-9d49-c97fd1ed203f

  2. Fernández Guerrero O. Cronos y Las Moiras. Lecturas de la temporalidad en la mitología griega. Pensamiento Revista de Investigación e Información Filosófica 2014; 70: 313-6. doi:10.14422/pen.v70.i263.y2014.004

  3. Santos-Bueso E, Sáenz-Francés F, García-Sánchez J. Átropos o Las Parcas. Francisco de Goya y Lucientes. Arch Soc Esp Oftalmol 2013; 88. doi:10.1016/j.oftal.2012.09.010

  4. Kuro-o M. The klotho proteins in health and disease. Nature Rev Nephrol 2018; 15: 27-44. doi:10.1038/s41581-018-0078-3

  5. Hu MC, Shiizaki K, Kuro-o M, Moe OW. Fibroblast growth factor 23 and Klotho: Physiology and pathophysiology of an endocrine network of mineral metabolism. Ann Rev Physiol 2013; 75: 503-33. doi:10.1146/annurev-physiol-030212-183727

  6. Kurosu H, Choi M, Ogawa Y, Dickson AS, Goetz R, Eliseenkova AV, et al. Tissue-specific expression of βKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21. J Biol Chem 2007; 282: 26687-95. doi:10.1074/jbc.m704165200

  7. L. YAS, Chertow GM, Luyckx VA, Marsden PA, Skorecki K, Taal MW. Chronic kidney disease – mineral bone disorder. Brenner & Rector’s the kidney, Philadelphia: Elsevier; 2020: 1813-5.

  8. Kuro-o M. Klotho as a regulator of fibroblast growth factor signaling and phosphate/calcium metabolism. Current Opin Nephrol Hypertension 2006; 15: 437-41. doi:10.1097/01.mnh.0000232885.81142.83

  9. Anuwatmatee S, Tang S, Wu BJ, Rye K-A, Ong KL. Fibroblast growth factor 21 in chronic kidney disease. Clin Chim Acta 2019; 489: 196-202. doi:10.1016/j.cca.2017.11.002




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Med Int Mex. 2024;40